X4 Pharmaceuticals secures $40M equity line with Lincoln Park Capital

X4 Pharmaceuticals, Inc

• Company may sell up to $40M of common stock to Lincoln Park over 24 months.
• Purchase price set at 97% of the lower of lowest or 3-day-average closing price.
• Regular purchases capped at 30k–60k shares per day based on stock price thresholds.
• Issued 137,099 commitment shares to Lincoln Park as a fee for entering the agreement.